SCHEMBL12460468

SCHEMBL12460468

CC1(C)c2cc(N(c3ccccc3)c3ccccc3)ccc2-c2cc3c(cc21)-c1ccc(N(c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c2nc(-c4ccccc4)nc(-c4ccccc4)n2)cc1C3(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ HPGD P15428 2/20 0.33
▸ PDE5A O76074 2/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ KDM1A O60341 2/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12460471 0.97 L3MBTL1 (0.36) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL12072912 0.93 L3MBTL1 (0.34) MAPTALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL12460923 0.92 PDK2 (0.34) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL14208883 0.91 L3MBTL1 (0.33) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL12072916 0.90 L3MBTL1 (0.36) MAPTALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL12133808 0.88 MEN1 (0.39) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL14208853 0.88 PDK2 (0.34) PDK2
SCHEMBL24255866 0.87 PDK2 (0.38) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL16383818 0.86 MAPT (0.39) MAPTALDH1A1L3MBTL1TDP1KDM4E
SCHEMBL17227653 0.86 L3MBTL1 (0.37) MAPTALDH1A1L3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9496504-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-15 — — US disclosed
US-9496504-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-15 — — US disclosed
US-20120305851-A1 Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2012-12-06 — — US disclosed
US-20120305851-A1 Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2012-12-06 — — US disclosed
WO-2011085781-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2011-07-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120305851-A1 Materials for Organic Electroluminescent Devices L1CAM, EFNA1, EPCAM MAPT 1887/4885ALDH1A1 27/4885L3MBTL1 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback